Literature DB >> 8947968

Renal drug transport: a review.

R Bendayan1.   

Abstract

Renal drug elimination involves three major processes: glomerular filtration, tubular secretion, and tubular reabsorption. Drug filtration is a simple unidirectional diffusion process. Renal tubular secretion and reabsorption are bidirectional processes that often involve both passive diffusion and carrier-mediated membrane processes. Various in vivo and in vitro techniques are available to study renal drug elimination and renal drug transport. The complete renal handling of a drug is best understood from data obtained from a combination of in vivo and in vitro methodologies. At the membranes of the renal proximal tubule, a number of carrier systems are involved in the tubular secretion and/or reabsorption of various drugs. Organic acid and base transporters are two major carrier systems important in the tubular transport of a number of organic acid and base drugs, respectively. Nucleoside and P-glycoprotein transporters appear to play an important role in renal tubular transport of dideoxynucleosides (e.g., zidovudine, dideoxyinosine) and digoxin, respectively. Clinically, these transporters are not only necessary for the renal tubular secretion and reabsorption of various drugs, but are also responsible in part for the drug's pharmacologic response (e.g., furosemide), drug-drug interactions of therapeutic or toxic importance, and drug nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947968

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).

Authors:  Mark J Dresser; Guangqing Xiao; Maya K Leabman; Andrew T Gray; Kathleen M Giacomini
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

Review 2.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 3.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

4.  Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum.

Authors:  S D Flanagan; L Z Benet
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

5.  Evaluating the regulation of transporter proteins and P-glycoprotein in rats with cholestasis and its implication for digoxin clearance.

Authors:  Parker Giroux; Patrick B Kyle; Chalet Tan; Joseph D Edwards; Michael J Nowicki; Hua Liu
Journal:  World J Gastrointest Pathophysiol       Date:  2022-05-22

6.  Membrane transporters in drug disposition.

Authors:  K M Giacomini
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

7.  Kidney Tubulointerstitial Fibrosis and Tubular Secretion.

Authors:  Pranav S Garimella; Ronit Katz; Sushrut S Waikar; Anand Srivastava; Insa Schmidt; Andrew Hoofnagle; Ragnar Palsson; Helmut G Rennke; Isaac E Stillman; Ke Wang; Bryan R Kestenbaum; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2021-09-24       Impact factor: 11.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.